Overview

  • Product nameAnti-KIF19 antibody
    See all KIF19 primary antibodies
  • Description
    Rabbit polyclonal to KIF19
  • Tested applicationsSuitable for: WB, ELISAmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Cow
  • Immunogen

    Synthetic peptide derived from the following sequence: EVSMSYLEIY NEMIRDLLNP SLGYLELRED SKGVIQVAGI TEVSTINAKE , corresponding to amino acids 145-195 of Human KIF19

  • Positive control
    • Jurkat cell lysate.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage bufferPreservative: None
    Constituents: 2% Sucrose, PBS
  • Concentration information loading...
  • PurityImmunogen affinity purified
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab49330 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.125 µg/ml. Predicted molecular weight: 111 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.
ELISA Use at an assay dependent concentration.

ELISA titre using peptide based assay: 1:62500.

Target

Anti-KIF19 antibody images

  • Anti-KIF19 antibody (ab49330) at 0.125 µg/ml + Jurkat cell lysate at 10 µg

    Secondary
    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 111 kDa
    Observed band size : ~65 kDa (why is the actual band size different from the predicted?)

References for Anti-KIF19 antibody (ab49330)

ab49330 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab49330.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"